BioXcel Therapeutics Inc BTAI:NASDAQ

Last Price$16.68NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.75(4.30%)
Bid (Size)$16.68 (11)
Ask (Size)$18.22 (2)
Day Low / High$16.18 - 17.89
Volume462.7 K
  • Latest Stories
  • Commentary and Analysis
BioXcel Therapeutics Starts Late-Stage Trial of Treatment Candidate for Agitation in Alzheimer's Disease
7:41AM ET 12/15/2021 MT Newswires

BioXcel Therapeutics (BTAI) said Wednesday it has started a late-stage trial evaluating BXCL501 for potential treatment of agitation in Alzheimer's disease...

Wall Street Set for Rebound After Another Omicron Slump
9:18AM ET 12/01/2021 MT Newswires

US stocks were set for a higher open Wednesday, recovering from a slump in the previous session amid concerns about the COVID-19 omicron variant and...

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday
9:13AM ET 12/01/2021 MT Newswires

Health care stocks were edging higher premarket Wednesday as the iShares NASDAQ Biotechnology Index (IBB) was up 0.50% and the Health Care SPDR (XLV) was...

FDA Extends Review of BioXcel Therapeutics' BXCL501; Shares Tumble Pre-Bell
8:19AM ET 12/01/2021 MT Newswires

BioXcel Therapeutics (BTAI) reported that the US Food and Drug Administration has extended the Prescription Drug User Fee Act date for its review of the...

Top Premarket Decliners
8:11AM ET 12/01/2021 MT Newswires

Aditxt (ADTX) shares slumped 21% after the company launched an underwritten public offering of common stock and warrants. BioXcel Therapeutics (BTAI)...

Top Midday Decliners
1:57PM ET 11/15/2021 MT Newswires

Telos (TLS) lagged sales estimates for Q3 and cut its full-year revenue guidance range to between $240 million and $245 million from the prior $283 million...

BioXcel Therapeutics Shares Sink on Goldman Sachs Downgrade
12:54PM ET 11/15/2021 MT Newswires

BioXcel Therapeutics (BTAI) shares were down almost 22% in Monday afternoon trading after Goldman Sachs downgraded its call on the clinical-stage drugmaker...

Top Premarket Decliners
8:22AM ET 11/15/2021 MT Newswires

Oatly Group (OTLY) shares slumped 14% after the company reported a wider Q3 net loss. EVgo (EVGO) shares declined 8%. The company disclosed in a 10-Q...

--Goldman Sachs Double Downgrades BioXcel Therapeutics to Sell From Buy, Adjusts Price Target to $24 From $55
5:28AM ET 11/15/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Berenberg Bank Adjusts BioXcel Therapeutics' Price Target to $73 From $70, Maintains Buy Rating
7:18AM ET 11/11/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...